A
88.61
-1.18 (-1.31%)
| 前收盘价格 | 89.79 |
| 收盘价格 | 90.09 |
| 成交量 | 143,966 |
| 平均成交量 (3个月) | 470,331 |
| 市值 | 1,975,265,024 |
| 预期市盈率 (P/E Forward) | 11.10 |
| 价格/销量 (P/S) | 2.34 |
| 股市价格/股市净资产 (P/B) | 4.55 |
| 52周波幅 | |
| 利润日期 | 7 Nov 2025 |
| 营业毛利率 | -3.12% |
| 营业利益率 (TTM) | 7.61% |
| 稀释每股收益 (EPS TTM) | -1.18 |
| 季度收入增长率 (YOY) | 43.40% |
| 季度盈利增长率 (YOY) | -13.90% |
| 总债务/股东权益 (D/E MRQ) | 142.03% |
| 流动比率 (MRQ) | 2.66 |
| 营业现金流 (OCF TTM) | 80.74 M |
| 杠杆自由现金流 (LFCF TTM) | 39.80 M |
| 资产报酬率 (ROA TTM) | 0.82% |
| 股东权益报酬率 (ROE TTM) | -4.57% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看涨 | 看涨 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看涨 | 看涨 | |
| 股票 | ANI Pharmaceuticals, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
0.1
| 分析师共识 | 2.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | 0.10 |
|
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 11.08% |
| 机构持股比例 | 100.39% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 121.00 (HC Wainwright & Co., 36.55%) | 购买 |
| 中 | 114.50 (29.22%) | |
| 低 | 90.00 (Truist Securities, 1.57%) | 保留 |
| 平均值 | 110.00 (24.14%) | |
| 总计 | 3 购买, 1 保留 | |
| 平均价格@调整类型 | 94.08 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Truist Securities | 09 Oct 2025 | 90.00 (1.57%) | 保留 | 90.78 |
| 11 Aug 2025 | 77.00 (-13.10%) | 保留 | 84.88 | |
| JP Morgan | 24 Sep 2025 | 115.00 (29.78%) | 购买 | 94.99 |
| HC Wainwright & Co. | 17 Sep 2025 | 121.00 (36.55%) | 购买 | 95.36 |
| 08 Aug 2025 | 93.00 (4.95%) | 购买 | 81.48 | |
| Guggenheim | 08 Sep 2025 | 114.00 (28.65%) | 购买 | 95.20 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| COOK MEREDITH | - | 88.61 | -400 | -35,444 |
| 累积净数量 | -400 | |||
| 累积净值 ($) | -35,444 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 88.61 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| COOK MEREDITH | 职员 | 13 Oct 2025 | 自动卖出 (-) | 400 | 88.61 | 35,444 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合